Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Optimizing Bispecific Antibody Use: Opportunities to Broaden Patient Access
Experts discuss which patient populations stand to benefit the most from recently approved bispecific therapies, identifying gaps or opportunities for further patient benefit, as well as the data gaps that exist in understanding the optimal use of bispecific antibodies across various cancer types.
EP: 1.Expanding Horizons: The Present and Future of Bispecific Antibodies Across Oncology
EP: 2.Revolutionizing Cancer Treatment: Key Bispecific Antibody Approvals
EP: 3.How Bispecific Antibodies Are Reshaping Cancer Care
Now Viewing
EP: 4.Optimizing Bispecific Antibody Use: Opportunities to Broaden Patient Access
EP: 5.Integrating Bispecific Antibodies in Community Oncology: Benefits and Considerations
EP: 6.Overcoming Key Operational Challenges in Integrating Bispecific Therapies
EP: 7.Partnerships in Bispecific Therapy: A Model for Supporting Community Oncology
EP: 8.Managing Complexity: Standardizing Workflows for Multiple Bispecific Therapies
EP: 9.Standardizing CRS Management and Ensuring Smooth Transitions of Care in Bispecific Therapy
EP: 10.Optimizing Bispecific Antibody Administration With EHR and Technology Solutions
EP: 11.Addressing Resource and Bandwidth Challenges in Bispecific Antibody Administration
EP: 12.Payer and Reimbursement Considerations for Bispecific Therapies
EP: 13.Emerging Therapeutic Areas for Bispecific Antibodies
EP: 14.Incorporating Bispecific Antibodies Earlier in Treatment and Improving Access in Underserved Communities
EP: 15.Future Breakthroughs: What’s Next for Bispecific Antibodies in Oncology?
Video content above is prompted by the following:
- What patient populations stand to benefit the most from recently approved bispecific therapies?
- Where are gaps or opportunities for patient populations to further benefit from bispecifics?
- What data gaps exist in understanding the optimal use of bispecific antibodies across various cancer types?
Related Videos
Related Content
Inflammatory Diets Raise Risk of Brain Disorders
April 10th 2025Article
Vegetables, fish oil, fruit, and high-fiber foods have anti-inflammatory effects, while low-fiber bread and animal fats are associated with pro-inflammatory effects. Diets heavier on these pro-inflammatory foods may be associated with higher risks of brain disorders.
Read More
